Adar Poonawalla

Serum's Adar Poonawalla Warns Of Delays As US Prioritizes Pfizer

World News | Chris Kay, Bloomberg | Friday March 5, 2021

The head of the world's biggest vaccine maker and the World Health Organization's chief scientist said manufacturers of coronavirus shots face a global shortage of the raw materials needed to churn out the inoculations.

"Please Be Patient": Adar Poonawalla To Nations Waiting For Vaccines

India News | Reported by Vishnu Som, Edited by Swati Bhasin | Sunday February 21, 2021

World's biggest vaccine maker Serum Institute of India's Adar Poonawalla this morning urged the nations to "be patient" amid the wait for Covishield, the coronavirus vaccine that the SII has developed in partnership with the Oxford University and British-Swedish pharma firm AstraZeneca.

Anand Mahindra's "One Shot Advertising Brief" For Adar Poonawalla

Offbeat | Written by Sanya Jain | Friday February 12, 2021

Want a 'sure-shot' way to make your partner happy this Valentine's Day? Give them the gift of a Covid-19 vaccine, a hilarious parody advertisement suggests.

"Best Investment": Adar Poonawalla On Budget Announcement On Vaccine

India News | Edited by Debanish Achom | Monday February 1, 2021

The owners of India's two top vaccine-makers have praised the Union Budget as a right step in the direction towards better healthcare amid the COVID-19 pandemic. Finance Minister Nirmala Sitharaman today announced Rs 35,000 crore to be deployed in India's vaccination drive, the world's largest.

"Hope To Launch Covovax By June 2021": Serum Institute's Adar Poonawalla

India News | Edited by Swati Bhasin | Saturday January 30, 2021

Serum Institute of India, the world's biggest vaccine maker, is hopeful of launching Covovax - developed in partnership with American vaccine developer Novavax - by June, its CEO Adar Poonawalla said today. The US-based pharma firm's Covid jab was found to be 89.3 per cent effective in a UK trial.

Serum Institute Fire Causes Loss Of Over Rs 1,000 Crore: Adar Poonawalla

India News | Press Trust of India | Friday January 22, 2021

The Serum Institute of India (SII) said it has suffered losses of over Rs 1,000 crore due to the massive fire that broke out a day before at its premises in Pune, while Maharashtra Chief Minister Uddhav Thackeray said that whether the blaze was an accident or sabotage will be known once the probe gets over.

"Vaccine Safe": Adar Poonawalla, Uddhav Thackeray On Serum Institute Fire

India News | Reported by Purva Chitnis, Edited by Deepshikha Ghosh | Friday January 22, 2021

A day after a massive fire at vaccine-maker Serum Institute of India's Pune facility, in which five people died, CEO Adar Poonawalla said the supply of the coronavirus vaccine Covishield would not be affected.

Latest News Live Updates: "Vaccine Safe", Says Adar Poonawalla On Serum Institute Fire

India News | Edited by Deepika Pundir, Nonika Marwaha | Friday January 22, 2021

A day after a massive fire at vaccine-maker Serum Institute of India's Pune facility, in which five people died, CEO Adar Poonawalla said there was no damage to any vaccine as none were being produced at the site.

"Deeply Saddened": Adar Poonawalla On Serum Institute Fire

India News | Edited by Divyanshu Dutta Roy | Thursday January 21, 2021

Serum Institute of India chief Adar Poonawala on Thursday said that no one had been seriously hurt in the fire at its vaccine-making facility in Pune which is at the heart of India's fight against the coronavirus.

Adar Poonawalla Takes Vaccine Jab To Endorse Covishield's Safety. Watch

India News | Edited by Chandrashekar Srinivasan | Saturday January 16, 2021

Serum Institute CEO Adar Poonawalla was administered the first dose of the Covishield coronavirus vaccine on Saturday afternoon, hours after Prime Minister Narendra Modi launched India's nationwide vaccination drive

"Vaccine More Effective If Longer Gap Between Doses": Serum To NDTV

India News | Reported by Vishnu Som, Edited by Deepshikha Ghosh | Saturday January 16, 2021

The efficacy of the Covishield vaccine goes up if the gap between two doses is more than 28 days, a top scientist at Adar Poonawalla's Serum Institute of India (SII) said today, a day before the launch of India's Covid vaccination drive.

"More Sleep": Birthday Wish For Serum's Adar Poonawalla From Wife Natasha

Offbeat | Edited by Stela Dey | Friday January 15, 2021

As Serum Institute of India's Adar Poonawalla celebrated his birthday on Thursday, his wife Natasha wished him "a little more sleep" after months of work on the Oxford-AstraZeneca's Covishield vaccine produced by their company.

Serum Institute Expects WHO Emergency Approval For Astrazeneca Shot Soon

India News | Reuters | Thursday January 14, 2021

The Serum Institute of India expects WHO emergency-use authorization soon for the Oxford University/AstraZeneca coronavirus vaccine, which it is producing for mid and low income countries, its chief executive said.

Serum Institute To Stockpile Novavax Vaccine From April: Adar Poonawalla

India News | Reuters | Thursday January 14, 2021

The Serum Institute of India, the world's biggest vaccine maker, will start stockpiling millions of doses of the Novavax coronavirus vaccine candidate starting around April, CEO Adar Poonawalla told the Reuters Next conference on Thursday.

"Emotional Moment", Tweets Adar Poonawalla As Covishield Vaccine Rolls Out

India News | Edited by Stela Dey | Tuesday January 12, 2021

Serum Institute of India CEO Adar Poonawalla tweeted that it was an "emotional moment" for his team at the Pune facility as the first shipments of the Covishield vaccine rolled out today. 56.5 lakh doses of Covishield, India's first coronavirus vaccine, left the SII this morning for various cities including Delhi, Chennai, Bengaluru, Lucknow, Kolka...